[Diagnosis and treatment of CMV and EBV Reactivation as well as Post-transplant Lymphoproliferative Disorders following Allogeneic Stem Cell Transplantation: An SFGM-TC report]

Pathol Biol (Paris). 2013 Aug;61(4):152-4. doi: 10.1016/j.patbio.2013.07.003. Epub 2013 Sep 4.
[Article in French]

Abstract

In the attempt to harmonize clinical practices between different French transplantation centers, the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) set up the third annual series of workshops which brought together practitioners from all member centers and took place in October 2012 in Lille. Here the SFGM-TC addressed the issue of post-transplant CMV and EBV reactivation, and EBV-related Lymphoproliferative Disorders.

Keywords: Allogeneic stem cell transplantation; Allogreffe de cellules souches hématopoïétiques; CMV; EBV.

Publication types

  • Practice Guideline

MeSH terms

  • Cytomegalovirus / physiology
  • Cytomegalovirus Infections / diagnosis*
  • Cytomegalovirus Infections / etiology
  • Cytomegalovirus Infections / therapy*
  • Donor Selection / standards
  • Epstein-Barr Virus Infections / diagnosis*
  • Epstein-Barr Virus Infections / etiology
  • Epstein-Barr Virus Infections / therapy*
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Hematopoietic Stem Cell Transplantation / standards
  • Herpesvirus 4, Human / physiology
  • Humans
  • Immunosuppression Therapy / standards
  • Immunosuppression Therapy / statistics & numerical data
  • Lymphoproliferative Disorders / diagnosis*
  • Lymphoproliferative Disorders / etiology
  • Lymphoproliferative Disorders / therapy*
  • Monitoring, Physiologic / standards
  • Primary Prevention / standards
  • Transplantation, Homologous
  • Virus Activation*